{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T07:03:09Z","timestamp":1781938989267,"version":"3.54.5"},"reference-count":44,"publisher":"Elsevier BV","issue":"21","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"The Netherlands Ministry of Economic Affairs"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.vaccine.2015.03.066","type":"journal-article","created":{"date-parts":[[2015,4,6]],"date-time":"2015-04-06T05:49:12Z","timestamp":1428299352000},"page":"2477-2484","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Stabilizing effects of excipients on dissociation of intact (146S) foot-and-mouth disease virions into 12S particles during storage as oil-emulsion vaccine"],"prefix":"10.1016","volume":"33","author":[{"given":"M.M.","family":"Harmsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.P.D.","family":"Fijten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.F.","family":"Westra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Dekker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1530","key":"10.1016\/j.vaccine.2015.03.066_bib0225","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1098\/rstb.2009.0100","article-title":"Options for control of foot-and-mouth disease: knowledge, capability and policy","volume":"364","author":"Paton","year":"2009","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"10.1016\/j.vaccine.2015.03.066_bib0230","first-page":"103","article-title":"Natural and vaccine induced immunity to FMD","volume":"288","author":"Doel","year":"2005","journal-title":"Curr Top Microbiol Immunol"},{"issue":"13","key":"10.1016\/j.vaccine.2015.03.066_bib0235","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/S0264-410X(96)00055-2","article-title":"International bank for foot-and-mouth disease vaccine: assessment of Montanide ISA 25 and ISA 206, two commercially available oil adjuvants","volume":"14","author":"Barnett","year":"1996","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2015.03.066_bib0240","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/0264-410X(90)90249-L","article-title":"International bank for foot-and-mouth disease vaccine: stability studies with virus concentrates and vaccines prepared from them","volume":"8","author":"Doel","year":"1990","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.03.066_bib0245","first-page":"71","article-title":"The structure of foot-and-mouth disease virus","volume":"288","author":"Fry","year":"2005","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2015.03.066_bib0250","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1038\/1921163a0","article-title":"Dissociation of foot-and-mouth disease virus into its nucleic acid and protein components","volume":"192","author":"Brown","year":"1961","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.vaccine.2015.03.066_bib0255","doi-asserted-by":"crossref","first-page":"444","DOI":"10.4049\/jimmunol.82.5.444","article-title":"Application of agar-gel diffusion analysis to a study of the antigenic structure of inactivated vaccines prepared from the virus of foot-and-mouth disease","volume":"82","author":"Brown","year":"1959","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2015.03.066_bib0260","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/0042-6822(65)90212-6","article-title":"Antibody response to the noninfectious 7 Mu component of the virus of foot-and-mouth disease","volume":"25","author":"Ceglowski","year":"1965","journal-title":"Virology"},{"issue":"3","key":"10.1016\/j.vaccine.2015.03.066_bib0265","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1099\/0022-1317-45-3-761","article-title":"Comparison of the antibodies elicited by the individual structural polypeptides of foot-and mouth disease and polio viruses","volume":"45","author":"Meloen","year":"1979","journal-title":"J Gen Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2015.03.066_bib0270","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/BF01314726","article-title":"Comparative immunogenicity of 146S, 75S and 12S particles of foot-and-mouth disease virus","volume":"73","author":"Doel","year":"1982","journal-title":"Arch Virol"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2015.03.066_bib0275","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0378-1135(94)90094-9","article-title":"Antibody response to 146S particle, 12S protein subunit and isolated VP1 polypeptide of foot-and-mouth disease virus type Asia-1","volume":"39","author":"Rao","year":"1994","journal-title":"Vet Microbiol"},{"issue":"3","key":"10.1016\/j.vaccine.2015.03.066_bib0280","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.vetmic.2008.07.011","article-title":"Rapid methodology for antigenic profiling of FMDV field strains and for the control of identity, purity and viral integrity in commercial virus vaccines using monoclonal antibodies","volume":"133","author":"Seki","year":"2009","journal-title":"Vet Microbiol"},{"issue":"2","key":"10.1016\/j.vaccine.2015.03.066_bib0285","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0092-1157(82)80028-0","article-title":"Qualitative assessment of 146S particles of foot-and-mouth disease virus in preparations destined for vaccines","volume":"10","author":"Doel","year":"1982","journal-title":"J Biol Stand"},{"key":"10.1016\/j.vaccine.2015.03.066_bib0290","first-page":"261","article-title":"Observations and implications of proteolysis in preparations of foot-and-mouth disease virus","volume":"50","author":"Doel","year":"1982","journal-title":"Dev Biol Stand"},{"issue":"4","key":"10.1016\/j.vaccine.2015.03.066_bib0295","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/BF01242879","article-title":"A simple method for the quantification of 140S particles of foot-and-mouth disease virus (FMDV)","volume":"45","author":"Barteling","year":"1974","journal-title":"Arch Gesamte Virusforsch"},{"issue":"12","key":"10.1016\/j.vaccine.2015.03.066_bib0300","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/0264-410X(95)00051-2","article-title":"Quantification of whole virus particles (146S) of foot-and-mouth disease virus in the presence of virus subunits (12S), using monoclonal antibodies in a sandwich ELISA","volume":"13","author":"Crowther","year":"1995","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2015.03.066_bib0305","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/1045-1056(90)90036-Y","article-title":"Quantification of intact 146S foot-and-mouth disease antigen for vaccine production by a double antibody sandwich ELISA using monoclonal antibodies","volume":"18","author":"Van Maanen","year":"1990","journal-title":"Biologicals"},{"issue":"27\u201328","key":"10.1016\/j.vaccine.2015.03.066_bib0310","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.1016\/j.vaccine.2008.04.062","article-title":"Production of monoclonal antibodies against whole virus particles of foot-and-mouth disease virus serotype O and A and their potential use in quantification of intact virus for vaccine manufacture","volume":"26","author":"Yang","year":"2008","journal-title":"Vaccine"},{"issue":"19","key":"10.1016\/j.vaccine.2015.03.066_bib0315","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1016\/j.vaccine.2010.02.084","article-title":"Characterization of foot-and-mouth disease virus antigen by surface-enhanced laser desorption ionization\u2013time of flight\u2013mass spectrometry in aqueous and oil-emulsion formulations","volume":"28","author":"Harmsen","year":"2010","journal-title":"Vaccine"},{"issue":"15","key":"10.1016\/j.vaccine.2015.03.066_bib0320","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1016\/j.vaccine.2011.01.069","article-title":"Effect of thiomersal on dissociation of intact (146S) foot-and-mouth disease virions into 12S particles as assessed by novel ELISAs specific for either 146S or 12S particles","volume":"29","author":"Harmsen","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.03.066_bib0325","series-title":"R: A Language and Environment For Statistical Computing","author":"R-Core-Team","year":"2013"},{"issue":"23","key":"10.1016\/j.vaccine.2015.03.066_bib0330","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1016\/S0264-410X(03)00249-4","article-title":"Correlation of haemagglutinin-neuraminidase and fusion protein content with protective antibody response after immunisation with inactivated Newcastle disease vaccines","volume":"21","author":"Maas","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.03.066_bib0335","first-page":"293","article-title":"Extraction and characterization of vaccine antigens from water-in-oil adjuvant formulations","volume":"308","author":"Miles","year":"2005","journal-title":"Methods Mol Biol"},{"issue":"April (2)","key":"10.1016\/j.vaccine.2015.03.066_bib0340","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1099\/0022-1317-1-2-247","article-title":"Nature of the inactivating action of trypsin on foot-and-mouth disease virus","volume":"1","author":"Wild","year":"1967","journal-title":"J Gen Virol"},{"issue":"9","key":"10.1016\/j.vaccine.2015.03.066_bib0345","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1271\/bbb.57.1445","article-title":"Encapsulation of chicken egg yolk immunoglobulin G (IgY) by liposomes","volume":"57","author":"Shimizu","year":"1993","journal-title":"Biosci Biotechnol Biochem"},{"issue":"3","key":"10.1016\/j.vaccine.2015.03.066_bib0350","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0168-3659(00)00277-7","article-title":"The effect of a water\/organic solvent interface on the structural stability of lysozyme","volume":"68","author":"van de Weert","year":"2000","journal-title":"J Control Release"},{"issue":"24","key":"10.1016\/j.vaccine.2015.03.066_bib0355","doi-asserted-by":"crossref","first-page":"9172","DOI":"10.1073\/pnas.0600263103","article-title":"Mapping epitopes and antigenicity by site-directed masking","volume":"103","author":"Paus","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2015.03.066_bib0360","article-title":"Proper quality control of formulated foot-and-mouth disease vaccines in countries with prophylactic vaccination is necessary","author":"Jamal","year":"2013","journal-title":"Transbound Emerg Dis"},{"issue":"33","key":"10.1016\/j.vaccine.2015.03.066_bib0365","doi-asserted-by":"crossref","first-page":"3327","DOI":"10.1016\/j.vaccine.2013.05.078","article-title":"Montanide ISA 201 adjuvanted FMD vaccine induces improved immune responses and protection in cattle","volume":"31","author":"Dar","year":"2013","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2015.03.066_bib0370","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/jps.10296","article-title":"Thermal stability of vaccines","volume":"92","author":"Brandau","year":"2003","journal-title":"J Pharm Sci"},{"issue":"13","key":"10.1016\/j.vaccine.2015.03.066_bib0375","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.addr.2011.07.006","article-title":"Protein-excipient interactions: mechanisms and biophysical characterization applied to protein formulation development","volume":"63","author":"Kamerzell","year":"2011","journal-title":"Adv Drug Deliv Rev"},{"issue":"2","key":"10.1016\/j.vaccine.2015.03.066_bib0380","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0378-5173(99)00152-0","article-title":"Instability, stabilization, and formulation of liquid protein pharmaceuticals","volume":"185","author":"Wang","year":"1999","journal-title":"Int J Pharm"},{"issue":"5","key":"10.1016\/j.vaccine.2015.03.066_bib0385","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.biologicals.2014.05.007","article-title":"Vaccine instability in the cold chain: mechanisms, analysis and formulation strategies","volume":"42","author":"Kumru","year":"2014","journal-title":"Biologicals"},{"issue":"2","key":"10.1016\/j.vaccine.2015.03.066_bib0390","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0168-3659(98)00148-5","article-title":"Stabilization of proteins against methylene chloride\/water interface-induced denaturation and aggregation","volume":"58","author":"Sah","year":"1999","journal-title":"J Control Release"},{"issue":"2","key":"10.1016\/j.vaccine.2015.03.066_bib0395","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1080\/02652040400026400","article-title":"Effect of additives on encapsulation efficiency, stability and bioactivity of entrapped lysozyme from biodegradable polymer particles","volume":"22","author":"Srinivasan","year":"2005","journal-title":"J Microencapsul"},{"issue":"3","key":"10.1016\/j.vaccine.2015.03.066_bib0400","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ejps.2006.01.010","article-title":"Influences of excipients on in vitro release and in vivo performance of tetanus toxoid loaded polymer particles","volume":"28","author":"Katare","year":"2006","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.vaccine.2015.03.066_bib0405","first-page":"103","article-title":"Stabilising oral poliovaccine at high ambient temperatures","volume":"87","author":"Newman","year":"1996","journal-title":"Dev Biol Stand"},{"issue":"6","key":"10.1016\/j.vaccine.2015.03.066_bib0410","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1021\/js960475h","article-title":"Size and conformational stability of the hepatitis A virus used to prepare VAQTA, a highly purified inactivated vaccine","volume":"86","author":"Volkin","year":"1997","journal-title":"J Pharm Sci"},{"issue":"10","key":"10.1016\/j.vaccine.2015.03.066_bib0415","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1002\/bit.260351013","article-title":"Lysine and other diamines dramatically stabilize poliovirus against thermoinactivation","volume":"35","author":"Dorval","year":"1990","journal-title":"Biotechnol Bioeng"},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2015.03.066_bib0420","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.vaccine.2005.01.133","article-title":"Sucrose fatty acid sulphate esters as novel vaccine adjuvant","volume":"24","author":"Hilgers","year":"2006","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2015.03.066_bib0425","doi-asserted-by":"crossref","first-page":"8","DOI":"10.7774\/cevr.2013.2.1.8","article-title":"Requirements for improved vaccines against foot-and-mouth disease epidemics","volume":"2","author":"Park","year":"2013","journal-title":"Clin Exp Vaccine Res"},{"issue":"6","key":"10.1016\/j.vaccine.2015.03.066_bib0430","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1128\/JVI.02245-10","article-title":"A single amino acid substitution in the capsid of foot-and-mouth disease virus can increase acid resistance","volume":"85","author":"Martin-Acebes","year":"2011","journal-title":"J Virol"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2015.03.066_bib0435","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/protein\/gzq069","article-title":"Virus engineering: functionalization and stabilization","volume":"24","author":"Mateu","year":"2011","journal-title":"Protein Eng Des Sel"},{"issue":"3","key":"10.1016\/j.vaccine.2015.03.066_bib0440","doi-asserted-by":"crossref","first-page":"e1003255","DOI":"10.1371\/journal.ppat.1003255","article-title":"Rational engineering of recombinant picornavirus capsids to produce safe, protective vaccine antigen","volume":"9","author":"Porta","year":"2013","journal-title":"PLoS pathogens"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15003850?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15003850?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T06:47:31Z","timestamp":1691563651000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X15003850"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":44,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S0264410X15003850"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.03.066","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stabilizing effects of excipients on dissociation of intact (146S) foot-and-mouth disease virions into 12S particles during storage as oil-emulsion vaccine","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.03.066","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}